Business

Total Voting Rights

EKF Diagnostics Holdings plc has announced its total voting rights, stating that the issued share capital comprises 431,963,112 ordinary shares of 1p each, with 141,000 shares held in treasury, resulting in 431,822,112 ordinary shares carrying voting rights. This figure will serve as the denominator for shareholders determining notification requirements under the FCA's Disclosure and Transparency Rules regarding their interests in the company's share capital. Disclaimer*

Ekf Diagnostics Holdings PlcMarch 2, 20265
Total Voting Rights

About this update from Ekf Diagnostics Holdings Plc

  EKF Diagnostics Holdings plc ("EKF" or the "Company")   Total Voting Rights   EKF Diagnostics Holdings plc  (AIM: EKF), the AIM-listed global diagnostics business, in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, announces that the total issued share capital of the Company consists of 431,963,112 ordinary shares of 1p each in the capital of the Company (" Ordinary Shares "), of which 141,000 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights will be 431,822,112.    The above figure of 431,822,122 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.   EKF Diagnostics Holdings plc www.ekfdiagnostics.com Julian Baines, Executive Chair Gavin Jones, Chief Executive Officer  via Walbrook PR Singer Capital Markets (Nominated Adviser & Broker) Tel: +44 (0)20 7496 3000 Phil Davies / Patrick Weaver Walbrook PR Limited Tel: +44 (0)20 7933 8780 or [email protected] Paul McManus / Alice Woodings  Mob: +44 (0)7980 541 893 / +44 (0) 7407 804 654       About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com )   EKF is an AIM-listed global diagnostics business focussed on:   ● Point-of-Care  analysers in the key areas of Hematology and Diabetes  ● Life Sciences  services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.   EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.  

View stock analysis, news, and events for Ekf Diagnostics Holdings Plc

More from Ekf Diagnostics Holdings Plc

All Ekf Diagnostics Holdings Plc news →